Rating History for Carbylan Therapeutics (CBYL) by Leerink

More Stocks Rated by Leerink | Latest Ratings for CBYL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/2/2016 N/A Downgrade Market Perform
(Outperform)		 1.80
(15.00)		 2.47
(0.68)		 -72.47% Details